Glaxosmithkline | 부채에 대한이자 비용



Interest Expense On Debt 변화 날짜
AbbVie USD 700M 90M 2025-03
Amgen USD 694M 29M 2025-06
AstraZeneca 303M 126M 2025-06
Aurora Cannabis CAD 1.78M 491K 2025-06
Bausch Health Companies USD 465M 135M 2025-06
Bristol-Myers Squibb USD 485M 9M 2025-06
Canopy Growth CAD 9.74M 7.03M 2025-06
Corcept Therapeutics 6M 6M 2024-06
Drreddys Laboratories INR 817M 60M 2024-12
Eli Lilly USD 249M 5.3M 2025-06
GlaxoSmithKline 184M 22M 2025-06
Glaxosmithkline 184M 5.95M 2025-06
J&J USD 128M 9M 2025-03
Merck USD 305M 8M 2025-06
Novartis USD 289M 19M 2025-06
Pacira USD 3.82M 110K 2025-06
Perrigo 39.6M 600K 2025-06
Pfizer USD 654M 0 2025-06
Prestige Brands USD 10.2M 275K 2025-06
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 148M 65M 2025-06
Supernus Pharmaceuticals USD 0 0 2024-12
Takeda 107.16B 56.83B 2025-06
Teva Pharmaceutical Industries USD 252M 40M 2025-06
Zoetis USD 53M 1000K 2025-06


Glaxosmithkline 부채에 대한이자 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Sep 2025.